Literature DB >> 22139088

Surgical site infections after post-bariatric abdominoplasty and flank liposuction: a case-control study focusing on the quantity of tissue removed.

Antonino Araco1, Gianpiero Gravante, Pietro Gentile, Valerio Cervelli.   

Abstract

We evaluated whether the quantity of fat removed during abdominoplasty and liposuction correlated with the occurrence of surgical site infection (SSI). We selected patients of similar age, sex, smoking status, obesity, and post-bariatric weight loss, retrospectively, and classified them into groups according to the development of SSI. The total amount of fat removed and aspirated was compared. The size of the flap removed from the abdomen and the amount of fat aspirated with liposuction differed significantly between the SSI and no-SSI groups (1.6 ± 0.2 vs. 0.6 ± 0.3 kg and 2 ± 0.2 vs. 0.9 ± 0.3 l, respectively; p < 0.001). The four SSI patients with the most fat removed (1.4 ± 0.2 kg) or aspirated (2 ± 0.1 l kg) had the deepest infections. SSI was strongly correlated with the size of flap resection (ρ = 0.80; p < 0.001) and liposuction (ρ = 0.72; p < 0.001). The quantity of fat removed or aspirated can influence the occurrence of SSI. If confirmed, these data could be used to better stratify patients according to their risk.

Entities:  

Mesh:

Year:  2011        PMID: 22139088     DOI: 10.1007/s00595-011-0076-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

Review 1.  Adipose tissue as an endocrine organ.

Authors:  Erin E Kershaw; Jeffrey S Flier
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

2.  Post-bariatric panniculectomy: pre-panniculectomy body mass index impacts the complication profile.

Authors:  Zachary M Arthurs; Daniel Cuadrado; Vance Sohn; Katharine Wolcott; Kelley Lesperance; Preston Carter; James Sebesta
Journal:  Am J Surg       Date:  2007-05       Impact factor: 2.565

3.  Abdominoplasty: a comparison of outpatient and inpatient procedures shows that it is a safe and effective procedure for outpatients in an office-based surgery clinic.

Authors:  Jamie I Spiegelman; Ronald H Levine
Journal:  Plast Reconstr Surg       Date:  2006-08       Impact factor: 4.730

Review 4.  Complications of 278 consecutive abdominoplasties.

Authors:  K J Stewart; D A Stewart; B Coghlan; D H Harrison; B M Jones; N Waterhouse
Journal:  J Plast Reconstr Aesthet Surg       Date:  2006-07-05       Impact factor: 2.740

5.  Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.

Authors:  Hye Soon Park; Jung Yul Park; Rina Yu
Journal:  Diabetes Res Clin Pract       Date:  2004-12-30       Impact factor: 5.602

6.  The outcome of abdominoplasty performed under conscious sedation: six-year experience in 153 consecutive cases.

Authors:  Zol B Kryger; Neil A Fine; Thomas A Mustoe
Journal:  Plast Reconstr Surg       Date:  2004-05       Impact factor: 4.730

Review 7.  Genotype, obesity and cardiovascular disease--has technical and social advancement outstripped evolution?

Authors:  P Zimmet; C R Thomas
Journal:  J Intern Med       Date:  2003-08       Impact factor: 8.989

8.  Wound infections in post-bariatric patients undergoing body contouring abdominoplasty: the role of smoking.

Authors:  G Gravante; A Araco; R Sorge; F Araco; D Delogu; V Cervelli
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

Review 9.  The genetics of obesity.

Authors:  Coleen M Damcott; Paul Sack; Alan R Shuldiner
Journal:  Endocrinol Metab Clin North Am       Date:  2003-12       Impact factor: 4.741

10.  A long-term study of outcomes, complications, and patient satisfaction with breast implants.

Authors:  Neal Handel; Tracy Cordray; Jaime Gutierrez; J Arthur Jensen
Journal:  Plast Reconstr Surg       Date:  2006-03       Impact factor: 4.730

View more
  1 in total

1.  Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.

Authors:  B Ascher; K Hoffmann; P Walker; S Lippert; U Wollina; B Havlickova
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-03-08       Impact factor: 6.166

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.